Andrew Hore – Annual AIM Awards, Best guess technology company – Advanced Oncotherapy (AVO)
Andrew Hore – It is coming up to the time for the annual AIM Awards. They will be announced on 8 October at Old Billingsgate in London and, in addition to the normal awards, there are also plans to mark the 20th anniversary with an award for the best performer over 20 years. Here is […]
Advanced Oncotherapy – Half year results
Advanced Oncotherapy announces unaudited results for the six months ended 30 June 2015. The Company remains on schedule in its technology development to have its LIGHT proton therapy system ready for patient treatment in London’s renowned Harley Street in 2017. The LIGHT system accelerates protons to the energy levels achieved in first-generation proton therapy machines but […]
Advanced Oncotherapy announces first milestone payment for China LIGHT system – interim results due tomorrow
First milestone payment for China LIGHT system & Completion of the first stage of installation of services to LIGHT Advanced Oncotherapy confirms that it has received its first milestone payment for a LIGHT Proton Therapy System. The payment was made by Sinophi Healthcare Limited in accordance with the purchase agreement for the Company’s LIGHT proton […]
Advanced Oncotherapy – Rocket Science, and the countdown has already begun
Advanced Oncotherapy (AVO) – Rocket Science, and the countdown has already begun. Article in UK Investor Magazine by Barry Gibb and Andy Senga of Beaufort Securities. Article image below, or go here to read the magazine.
Advanced Oncotherapy – Change of Registered Office & Trading Address
Advanced Oncotherapy announces a change of Registered Office & Trading Address. The group registered office address is now: Level 17, Dashwood House, 69 Old Broad Street, London EC2M 1QS. And its trading and correspondence address is: Third Floor, Clearwater House, 4-7 Manchester Street, London W1U 3AE Advanced Oncotherapy Plc […]
An investing entry point for Advanced Oncotherapy (AVO)?
An investing entry point for Advanced Oncotherapy (AVO)? Alan Green discusses on TipTV. Click below.
Advanced Oncotherapy – Broker Notes
Advanced Oncotherapy Broker Notes Westhouse retains a Buy recommendation with a Target Price of 25p. Advanced Oncotherapy (AVO) – Analyst Robert Sanders – On Schedule. Two CCL modules are announced as ready for high-power testing. This is the first time two CCL modules will be tested together…the finished proton beam cancer treatment machine (LIGHT system) […]
Daily Telegraph – Shares in Advanced Oncotherapy jump amid chatter of Chinese contract win
By Tara Cunningham, Business Reporter, Daily Telegraph: As global equity markets faltered last week, Advanced Oncotherapy bucked the trend amid chatter of a contract win in China. Speculation Advanced Oncotherapy, the developer of next-generation proton therapy systems for cancer treatment, secured a second contract in China drove the share price higher last week. While global […]
Advanced Oncotherapy – CCL modules ready for high-power testing
Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that the two Coupled Cavity Linac modules are now ready for high-power testing at the Company’s facility in Geneva. These two modules will be tested at high power by using the Radio Frequency Power Units provided by ScandiNova and Toshiba and it is […]
Advanced Oncotherapy (AVO) – Sinophi agreement with Jilin University
Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, confirms that its partner for the Chinese market, Sinophi Healthcare Limited, has recently signed a Framework Agreement with China-Japan Union Hospital of Jilin University in relation to a proton therapy centre. Advanced Oncotherapy confirms that this Framework Agreement does not as yet […]